MetronomIc CApecitabine and DOcetaxel as Second-line Chemotherapy for Advanced Gastric Cancer
Clinical trial NCT02007148 · UNKNOWN
Trial details
- NCT number
- NCT02007148
- Sponsor
- International Group of Endovascular Oncology
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2021-10-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.